Replies to post #17309 on Oncolix Inc. (fka ONCX)

[reaper247]

LOL, laraz…what?

Phase 1 a bust?

In 805 days, Oncolix is yet to furnish a provable verifiable recruit

That is bufoonery.

Oncolix dosed a few patients in their initial phase one trial and supplied that information in SEC docs.

The FDA has allowed Oncolix to continue phase one clinical trials which is happening as we speak.

Now calculate how many shares were sold to Toxic Financers in the last 805 days times the ratio of PPS decline?

We can do this again.

The PPS prior to notes being issued was .05 ranged for several months. The PPS hasn’t really suffered much since the notes were added to the O/S.

Again, even with an O/S of 200,000,000, @ a PPS of .0265 ONCX a market cap of just $5,300,000.

A company in current phase one FDA clinical trials can easily support a market valuation of $100,000,000.

A PPS gain of 2000% from current levels would give ONCX of around $100,000,000 which is probably where it should be.

Its just math. Anyone can run the numbers.

A 2000% gain from here is completely possible. A 1000% gain from here almost seems likely at this point.

Hope that helps.

IMO and FWIW.